Vice President and Executive Director Xie Xin increased his holdings of SINO BIOPHARM (01177) by 1 million shares, with an average price of approximately HK $6.41 per share.

19:11 24/12/2025

According to the latest data from the Hong Kong Stock Exchange, Vice President and Executive Director, Xie Xin, increased his stake in China Biopharmaceuticals (01177) on December 24 by purchasing 1 million shares at a price of 6.4068 Hong Kong dollars per share, for a total amount of 6.4068 million Hong Kong dollars.

The latest information from the Hong Kong Stock Exchange shows that on December 24, Vice President and Executive Director Xie Xin increased his holding of 1 million shares of SINO BIOPHARM (01177) at a price of 6.4068 Hong Kong dollars per share, with a total amount of 6.4068 million Hong Kong dollars. The latest number of shares held after the increase is approximately 361 million shares, with the latest shareholding ratio being 1.92%.

HK Stock Market Move | XPENG-W (09868) rose more than 6%, the company accelerating its layout in the Middle East and Africa markets, recently reaching a strategic cooperation with a well-known distributor in Mauritius.

HK Stock Market Move | ELIFE HLDGS (00223) resumed trading after more than 1 year and surged 1.61 times in early trading.

Guosen: Maintaining an "outperform" investment rating on LI NING (02331) with a reasonable valuation range of HKD 21.20-22.30.

HK Stock Market Move | ELIFE HLDGS (00223) resumed trading after more than 1 year and surged 1.61 times in early trading.

Guosen: Maintaining an "outperform" investment rating on LI NING (02331) with a reasonable valuation range of HKD 21.20-22.30.